Spectrum Pharmaceuticals

Spectrum Pharmaceuticals, Inc., a subsidiary of Assertio Holdings, Inc. Assertio is a leading commercial pharmaceutical company.

[Spectrum Pharmaceuticals @sppirx]

Catch us in the exhibit hall this week at the @ACCC 42nd #NOC2025! We’re looking forward to connecting with oncology care providers from across the country and exploring the latest innovations shaping cancer care. #NOC2025 #OncologyInnovation

[Spectrum Pharmaceuticals @sppirx]

We’re just days away from the #NCODAFallSummit in Orlando, Florida. Our team can’t wait to connect with you at booth #39 to discuss our #oncology product. Stop by next week to learn more.

#Oncology #NCODA #Cancer

[Spectrum Pharmaceuticals @sppirx]

We’re heading to Orlando next week for the annual Community Oncology Conference (#COA2025).

Stop by Booth #800 to connect with our team and hear how our FDA-Approved #oncology product is helping support patient care in community practices.

#CancerCare #CommunityOncology

[Spectrum Pharmaceuticals @sppirx]

Attending the NCODA International Spring Forum in Denver next week?
Stop by Booth #38 to meet our team and hear more about our commitment to advancing care with our approved #oncology product.
#NCODA25 #CancerCare

[Spectrum Pharmaceuticals @sppirx]

Did you know that #FebrileNeutropenia (FN) is a common complication among cancer patients receiving therapy. Studies estimate that up to 80% of those with hematological malignancies receiving #chemotherapy develop FN and require #SupportiveCare.

[Spectrum Pharmaceuticals @sppirx]

The Spectrum team is heading to Orlando, FL this week for #NCCN2025.

If you are attending, please stop by Booth 410 to learn more about our #oncology product.

We hope to see you in Orlando.

#CancerCare #NCCN25

[Spectrum Pharmaceuticals @sppirx]

Understanding #SevereNeutropenia and #FebrileNeutropenia

[Spectrum Pharmaceuticals @sppirx]

Neutropenia is a common side effect of chemotherapy

#CIN #Neutropenia #Chemotherapy

[Spectrum Pharmaceuticals @sppirx]

Join us at the 42nd Annual Miami Breast Conference in Miami, FL. We look forward to presenting our latest data in one of the Poster Sessions. Hope to connect with you there!

View the schedule: https://t.co/RK5qMIdBxs

#MiamiBreastConference #MBCC #BreastCancer

[Spectrum Pharmaceuticals @sppirx]

If you're attending the ACCC 51st Annual Meeting & Cancer Business Summit in Washington, DC next week, be sure to check out our presentation during
the Poster Session on Wednesday, March 5th. Hope to see you there.

View the agenda: https://t.co/9zxp2ug2qE

#ACCC25 #BreastCancer

[Spectrum Pharmaceuticals @sppirx]

#CIN #Neutropenia #Chemotherapy

[Spectrum Pharmaceuticals @sppirx]

Learn more about Chemotherapy Induced Neutropenia (CIN) by visiting: https://t.co/i5Q8RSvEHC

#CIN #Neutropenia

[Spectrum Pharmaceuticals @sppirx]

World Cancer Day is a global initiative led by the Union for International Cancer Control (UICC). The theme for 2025 is “United by Unique”.
Learn more about how you can rewrite the future of cancer care: https://t.co/mI0hqN6rGG

#WorldCancerDay #UnitedByUnique #CancerAwareness

[Spectrum Pharmaceuticals @sppirx]

Are you attending #SABCS? We are presenting a poster at this year's conference. We hope to see you during Poster Session 4 on Thursday, December 12th.

View the schedule: https://t.co/sfhqIGV0TY

#SABCS24 #BreastCancer

[Spectrum Pharmaceuticals @sppirx]

Visit us today at booth #1358 at #ASHP24! Let’s discuss how we can collaborate—we look forward to connecting with you.

#CancerCare #Oncology

[Spectrum Pharmaceuticals @sppirx]

Why #CancerScreening matters

[Spectrum Pharmaceuticals @sppirx]

Are you attending #SABCS? We are presenting a poster at this year's conference. We hope to see you during Poster Session 4 on Thursday, December 12th.

View the schedule: https://t.co/sfhqIGUt4q

#SABCS24 #BreastCancer

[Spectrum Pharmaceuticals @sppirx]

Our team is looking forward to joining @ASHPOfficial at #ASHP24 in New Orleans next week. Visit us at Booth #1358 to connect and discover how we’re supporting pharmacy professionals. See you there! https://t.co/9oJdVL3cdr

#CancerCare #Oncology

[Spectrum Pharmaceuticals @sppirx]

Its Day 2 of #NCODAFallSummit in Orlando, Florida. Don’t forget to stop by booth #64 to see our team and learn about our #Oncology product.
#NCODA #Cancer

[Spectrum Pharmaceuticals @sppirx]

Did you know that #FebrileNeutropenia (FN) is a common complication among cancer patients receiving therapy. Studies estimate that up to 80% of those with hematological malignancies receiving #chemotherapy develop FN and require #SupportiveCare.